Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

GlycoDesign seeking licensees for its carbohydrate-processing inhibitor GD0039

June 3, 1998

Vinflunine, a vinca alkaloid with more potent activity than vinorelbine in preclinical models

June 2, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

Liarozole, a RAMBA with clinical efficacy in treating prostate cancer

June 2, 1998

Sparta receives FDA approval for phase II/III trials of Spartaject busulfan

June 2, 1998

Agents for tumors and tumor metastasis synthesized at Ishihara Sangyo

June 1, 1998

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

June 1, 1998

Imutech and Harvard Medical School join forces for clotrimazole development

June 1, 1998

New protein farnesyltransferase inhibitors prepared by Zeneca

June 1, 1998

Somatostatin analogue TT-232 prevents proliferation of pancreatic cancer

May 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...